A Role for Interleukin-1 Alpha in Immunologically Mediated Intestinal Pathology

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 1993 Sep 1

PMID 8244450

Citations 7

Authors

A M Mowat

A K Hutton

P Garside

M Steel

Affiliations

Soon will be listed here.

Abstract

Interleukin-1 (IL-1) is an important mediator of inflammation and has been implicated in several forms of immunopathology. Here we have investigated whether IL-1 plays a role in the enteropathy which occurs during a graft-versus-host reaction (GVHR) in mice. Non-irradiated (CBA x BALB/c) F1 mice with GVHR had increased production of IL-1 and treatment with rabbit anti-IL-1 alpha antibodies abolished the crypt hyperplasia and significantly reduced the parallel increase in crypt length which occurs in the jejunum. Antibody treatment had no effect on the accompanying increase in intraepithelial lymphocyte (IEL) counts or on the splenomegaly. Recombinant IL-1 itself produced villus atrophy, crypt hyperplasia and increased IEL counts in normal mice and stimulated the proliferation of an intestinal epithelial cell line in vitro. We propose that IL-1 plays an effector role in immunologically mediated enteropathy, either via direct effects on epithelial cells or secondary to an action on other, stromal cells in the mucosa.

Citing Articles

Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism.

Leveson-Gower D, Olson J, Sega E, Luong R, Baker J, Zeiser R Blood. 2011; 117(11):3220-9.

PMID: 21258007 PMC: 3317770. DOI: 10.1182/blood-2010-08-303008.

Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease model.

Jones S, Murphy G, Friedman T, Korngold R J Clin Invest. 2003; 112(12):1880-6.

PMID: 14679183 PMC: 296997. DOI: 10.1172/JCI19427.

Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine.

Harris N, Barletta R Clin Microbiol Rev. 2001; 14(3):489-512.

PMID: 11432810 PMC: 88986. DOI: 10.1128/CMR.14.3.489-512.2001.

Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease.

Daum S, Bauer U, Foss H, Schuppan D, STEIN H, Riecken E Gut. 1998; 44(1):17-25.

PMID: 9862821 PMC: 1760063. DOI: 10.1136/gut.44.1.17.

Interactions between stromal cell--derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia.

Bajaj-Elliott M, Poulsom R, Pender S, Wathen N, MacDonald T J Clin Invest. 1998; 102(8):1473-80.

PMID: 9788959 PMC: 508996. DOI: 10.1172/JCI2792.

References

MacDonald T, Ferguson A . Hypersensitivity reactions in the small intestine. III. The effects of allograft rejection and of graft-versus-host disease on epithelial cell kinetics. Cell Tissue Kinet. 1977; 10(4):301-12. View

McCarthy Jr P, Abhyankar S, Neben S, Newman G, Sieff C, Thompson R . Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease. Blood. 1991; 78(8):1915-8. View

Blay J, Brown K . Characterization of an epithelioid cell line derived from rat small intestine: demonstration of cytokeratin filaments. Cell Biol Int Rep. 1984; 8(7):551-60. DOI: 10.1016/0309-1651(84)90054-7. View

Mowat A, Borland A, Parrott D . Hypersensitivity reactions in the small intestine. VII. Induction of the intestinal phase of murine graft-versus-host-reaction by Lyt 2- T cells activated by I-A alloantigens. Transplantation. 1986; 41(2):192-8. View

Vassalli P . Gut injury in mouse graft-versus-host reaction. Study of its occurrence and mechanisms. J Clin Invest. 1986; 77(5):1584-95. PMC: 424562. DOI: 10.1172/JCI112474. View

Wingfield P, Payton M, Graber P, Rose K, Dayer J, Shaw A . Purification and characterization of human interleukin-1 alpha produced in Escherichia coli. Eur J Biochem. 1987; 165(3):537-41. DOI: 10.1111/j.1432-1033.1987.tb11472.x. View

Piguet P, Grau G, Allet B, Vassalli P . Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J Exp Med. 1987; 166(5):1280-9. PMC: 2189667. DOI: 10.1084/jem.166.5.1280. View

Waage A, Espevik T . Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice. J Exp Med. 1988; 167(6):1987-92. PMC: 2189698. DOI: 10.1084/jem.167.6.1987. View

Mowat A, Felstein M, Borland A, Parrott D . Experimental studies of immunologically mediated enteropathy. Development of cell mediated immunity and intestinal pathology during a graft-versus-host reaction in irradiated mice. Gut. 1988; 29(7):949-56. PMC: 1433779. DOI: 10.1136/gut.29.7.949. View

10.

Mosmann T, Fong T . Specific assays for cytokine production by T cells. J Immunol Methods. 1989; 116(2):151-8. DOI: 10.1016/0022-1759(89)90198-1. View

11.

Henderson B, Pettipher E . Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol. 1989; 75(2):306-10. PMC: 1542106. View

12.

Mowat A, Sprent J . Induction of intestinal graft-versus-host reactions across mutant major histocompatibility antigens by T lymphocyte subsets in mice. Transplantation. 1989; 47(5):857-63. DOI: 10.1097/00007890-198905000-00022. View

13.

Hopkins S, Humphreys M . Simple, sensitive and specific bioassay of interleukin-1. J Immunol Methods. 1989; 120(2):271-6. DOI: 10.1016/0022-1759(89)90252-4. View

14.

Mahida Y, Wu K, Jewell D . Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut. 1989; 30(6):835-8. PMC: 1434123. DOI: 10.1136/gut.30.6.835. View

15.

Butler L, Layman N, Cain R, Riedl P, Mohler K, Bobbitt J . Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention. Clin Immunol Immunopathol. 1989; 53(3):400-21. DOI: 10.1016/0090-1229(89)90003-2. View

16.

Mowat A . Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology. 1989; 68(1):18-23. PMC: 1385499. View

17.

Wu S, Miyamoto T . Radioprotection of the intestinal crypts of mice by recombinant human interleukin-1 alpha. Radiat Res. 1990; 123(1):112-5. View

18.

Rabinovitch A, Baquerizo H, Pukel C, Sumoski W . Effects of cytokines on rat pancreatic islet cell monolayer cultures: distinction between functional and cytotoxic effects on islet beta-cells. Reg Immunol. 1989; 2(2):77-82. View

19.

Smith S, Terminelli C, Phillips D . A study of cytokine production in acute graft-vs-host disease. Cell Immunol. 1991; 134(2):336-48. DOI: 10.1016/0008-8749(91)90307-w. View

20.

Mowat A, Ferguson A . Intraepithelial lymphocyte count and crypt hyperplasia measure the mucosal component of the graft-versus-host reaction in mouse small intestine. Gastroenterology. 1982; 83(2):417-23. View